Clincosm LogoSign in Get a demo

De-identified Human Tissue Project

Sponsor
University of Central Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT06082687
Collaborator
(none)
1,000,000
Enrollment
1
Location
59.6
Anticipated Duration (Months)
16788.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The objective of this De-Identified Human Tissue Project is the receipt of de-identified human tissue from medical, surgical, and clinical facilities. The human tissue can be fresh or paraffinized. The human tissue will be picked up by the clinical research team and transferred to research scientists of the University of Central Florida's College of Medicine (COM) or Burnett School of Biomedical Sciences (BSBS) for storage and testing according to their separate IRB-approved or IRB-exempted protocols. These separate protocols cannot be for genetic testing. The Project does not receive human tissue resulting from termination of pregnancy.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000000 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    De-identified Human Tissue Project for Use With Translational, Biomedical Research at UCF College of Medicine and Burnett School of Biomedical Sciences
    Actual Study Start Date :
    Sep 14, 2022
    Anticipated Primary Completion Date :
    Sep 1, 2027
    Anticipated Study Completion Date :
    Sep 1, 2027

    Arms and Interventions

    Arm Intervention/Treatment
    de-identified human tissue

    This Project will receive de-identified human tissue from cooperating institutions for unknown/undisclosed donors.

    Outcome Measures

    Primary Outcome Measures

    1. Receipt of de-identified human tissue for research [5 years]

      The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion:
    • de-identified human tissue from cooperating institutions for unknown/undisclosed donors.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Central Florida Orlando Florida United States 32816

    Sponsors and Collaborators

    • University of Central Florida

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Central Florida
    ClinicalTrials.gov Identifier:
    NCT06082687
    Other Study ID Numbers:
    • STUDY00004397
    First Posted:
    Oct 13, 2023
    Last Update Posted:
    Oct 19, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Central Florida
    Tissue
    surgery
    donate

    Study Results

    No Results Posted as of Oct 19, 2023